The Endocrinology and Metabolism Research Institute was established in 1993 as the Endocrinology and Metabolism Research Centre of Tehran University of Medical Sciences in Dr. Shariati University Hospital Campus in Tehran.
The primary goal of the centre was to lay the foundation for a multi disciplinary research complex encompassing both clinical and experimental basic medical sciences aspects of endocrinology and metabolism with a focus on diabetes and osteoporosis. As a result of its outstanding performance, the Endocrinology and Metabolism Research Centre (EMRC) was promoted to the Endocrinology and Metabolism Research Institute (EMRI) by the Ministry of Health and Medical Education of the Islamic Republic of Iran in 2010. In 2012, the Institute was officially promoted to the highest possible status of a research organization in Iran.
We are determined to harness full capacity of resources to become the highest ranking research institute in the field of endocrine diseases in the region. The EMRI 's fields of interest includes, but are not limited to, diabetes, osteoporosis, endocrinology, biosensors, metabolic disorders, obesity, non communicable diseases, elderly health, chronic diseases, cell therapy and regenerative medicine, metabolomics and genomics, as well as personalized medicine. Each of the abovementioned fields of research is covered by a designated research center affiliated to EMRI.
Since its establishment, the EMRI has been a pioneer in implementing and developing strategies in the field of promotion of public health and implementation of preventive strategies at a national scale. In order to achieve its goal, the EMRI has been in close collaboration with the public health sectors of the government such as the Ministry of Health and Medical Education as well as several Iranian nongovernmental organizations.
Moreover, EMRI has been authorized as the collaborating institute for education, management, and research on osteoporosis and diabetes by the World Health Organization. The most prominent features of the institute, to name a few, are: the well equipped and modern laboratories such as food and drug, hormone, bionanotechnology, molecular and cellular biology, and genetic research laboratories. Clinical facilities, diagnostic laboratories, and imaging departments are also integrated into the research institute in order to ensure that they cover a wide range of activities in the field.
This multi-disciplinary biomedical and clinical research institute looks forward to expanding capacity for basic, clinical, and translational research on diabetes and metabolic disorders. Any offer of assistance, partnership, or collaboration which could assist us to achieve our goal is warmly welcomed. In the end, I wish to express our sincere willingness to provide service to research centers, universities, and organizations with similar interests all around the world, and, specifically, the regional countries.